Teva Pharmaceutical Industries Ltd. (United States) is listed on the NYSE and has a market capitalization of $37.42 billion, with shareholders equity totaling $8.23 billion.
The company employs approximately 40.216 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Teva Pharmaceutical Industries Ltd. reported $17.35 billion in revenue, generating net income of $1.56 billion.
Key financial metrics include a P/E ratio of 23.93, a price-to-book (P/B) ratio of 4.55, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TEVA.